Sale!

FGFR1 Gene Osteoglophonic Dysplasia Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The FGFR1 Gene Osteoglophonic Dysplasia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FGFR1 gene, which are linked to osteoglophonic dysplasia. This rare genetic disorder is characterized by abnormalities in bone growth and development, leading to distinctive facial features, dwarfism, and other skeletal anomalies. The test, priced at 4400 AED, involves analyzing the patient’s DNA to detect specific genetic alterations in the FGFR1 gene, providing crucial information for accurate diagnosis, management, and genetic counseling for affected individuals and their families. DNA Labs UAE, with its state-of-the-art facilities and expert geneticists, ensures precise and reliable test results, offering a vital tool in the understanding and treatment of osteoglophonic dysplasia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FGFR1 Gene Osteoglophonic Dysplasia Genetic Test

Are you concerned about osteoglophonic dysplasia and its genetic implications? DNA Labs UAE offers the FGFR1 Gene Osteoglophonic Dysplasia Genetic Test to help you understand this rare genetic disorder. Read on to learn more about the test, its components, cost, symptoms, diagnosis, and more.

Test Name: FGFR1 Gene Osteoglophonic Dysplasia Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Dysmorphology

Doctor: Pediatrics

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for FGFR1 Gene Osteoglophonic Dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Osteoglophonic Dysplasia NGS Genetic DNA Test gene FGFR1

Test Details

The FGFR1 gene is associated with a condition called osteoglophonic dysplasia. Osteoglophonic dysplasia is a rare genetic disorder characterized by abnormal bone development and facial features. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. This allows for a more comprehensive analysis of an individual’s genetic makeup and can help identify mutations or variations in the FGFR1 gene that may be causing osteoglophonic dysplasia.

NGS genetic testing for osteoglophonic dysplasia involves obtaining a DNA sample from the individual, typically through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations or variations in the FGFR1 gene that may be present. This type of genetic testing can provide valuable information for diagnosis, prognosis, and management of osteoglophonic dysplasia. It can also help determine the risk of passing the condition on to future generations and inform reproductive decisions.

It is important to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and potential implications of NGS genetic testing for osteoglophonic dysplasia.

Test Name FGFR1 Gene Osteoglophonic dysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for FGFR1 Gene Osteoglophonic dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FGFR1 Gene Osteoglophonic dysplasia NGS Genetic DNA Test gene FGFR1
Test Details

The FGFR1 gene is associated with a condition called osteoglophonic dysplasia. Osteoglophonic dysplasia is a rare genetic disorder characterized by abnormal bone development and facial features.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that uses advanced sequencing technologies to analyze multiple genes simultaneously. This allows for a more comprehensive analysis of an individual’s genetic makeup and can help identify mutations or variations in the FGFR1 gene that may be causing osteoglophonic dysplasia.

NGS genetic testing for osteoglophonic dysplasia involves obtaining a DNA sample from the individual, typically through a blood or saliva sample. The DNA is then sequenced using NGS technology to identify any mutations or variations in the FGFR1 gene that may be present.

This type of genetic testing can provide valuable information for diagnosis, prognosis, and management of osteoglophonic dysplasia. It can also help determine the risk of passing the condition on to future generations and inform reproductive decisions.

It is important to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and potential implications of NGS genetic testing for osteoglophonic dysplasia.